跳到正文
FDA 官方药品与生物制品信息·AI 评分45

FDA 延长使用日期清单:Hospira、辉瑞与 Baxter 多批次药品列入

Search List of Extended Use Dates to Assist with Drug Shortages

AI 导读

FDA 发布延长使用日期清单以协助应对药品短缺,涉及 Hospira(辉瑞旗下)的布比卡因脊麻注射液 0.75% 和葡萄糖注射液 25%,辉瑞的 Bicillin L-A(苄星青霉素 G)及 Baxter 的氟马西尼注射液。

正文 · 原文

Bupivacaine Spinal Injection 0.75%, 15 mg/2 mL (7.5 mg/mL) in Dextrose 8.25%, glass ampuleHospira, a Pfizer company0409-1761-10GH44331-Oct-20251-Oct-2026Bupivacaine Spinal Injection 0.75%, 15 mg/2 mL (7.5 mg/mL) in Dextrose 8.25%, glass ampuleHospira, a Pfizer company0409-1761-62GY79511-Feb-20261-Feb-2027Bupivacaine Spinal Injection 0.75%, 15 mg/2 mL (7.5 mg/mL) in Dextrose 8.25%, glass ampuleHospira, a Pfizer company0409-3613-01LD283128-Feb-202628-Feb-2027Bupivacaine Spinal Injection 0.75%, 15 mg/2 mL (7.5 mg/mL) in Dextrose 8.25%, glass ampuleHospira, a Pfizer company0409-3613-01LD283228-Feb-202628-Feb-2027Bupivacaine Spinal Injection 0.75%, 15 mg/2 mL (7.5 mg/mL) in Dextrose 8.25%, glass ampuleHospira, a Pfizer company0409-3613-01LD285528-Feb-202628-Feb-2027Bupivacaine Spinal Injection 0.75%, 15 mg/2 mL (7.5 mg/mL) in Dextrose 8.25%, glass ampuleHospira, a Pfizer company0409-3613-01LE256328-Feb-202628-Feb-2027Dextrose Injection 25%, 2.5 g/10 mL (250 mg/mL) plastic syringeHospira, a Pfizer company0409-1775-10LH71031-May-20261-Oct-2026Dextrose Injection 25%, 2.5 g/10 mL (250 mg/mL) plastic syringeHospira, a Pfizer company0409-1775-40LH71031-May-20261-Oct-2026Dextrose Injection 25%, 2.5 g/10 mL (250 mg/mL) plastic syringeHospira, a Pfizer company0409-1775-10LH7106 1-May-20261-Oct-2026Dextrose Injection 25%, 2.5 g/10 mL (250 mg/mL) plastic syringeHospira, a Pfizer company0409-1775-40LH7106 1-May-20261-Oct-2026Dextrose Injection 25%, 2.5 g/10 mL (250 mg/mL) plastic syringeHospira, a Pfizer company0409-1775-10LH71081-May-20261-Oct-2026Dextrose Injection 25%, 2.5 g/10 mL (250 mg/mL) plastic syringeHospira, a Pfizer company0409-1775-40LH71081-May-20261-Oct-2026Bicillin L-A (penicillin G benzathine injectable suspension), 1,200,000 units/2 mLPfizer, Inc.60793-701-10FT967630-Sep-202530-Sep-2026Bicillin L-A (penicillin G benzathine injectable suspension), 1,200,000 units/2 mLPfizer, Inc.60793-701-10FC393831-Oct-202531-Oct-2026Bicillin L-A (penicillin G benzathine injectable suspension), 1,200,000 units/2 mLPfizer, Inc.60793-701-10GL295528-Feb-202628-Feb-2027Bicillin L-A (penicillin G benzathine injectable suspension), 1,200,000 units/2 mLPfizer, Inc.60793-701-10GT248931-Mar-202631-Mar-2027Bicillin L-A (penicillin G benzathine injectable suspension), 1,200,000 units/2 mLPfizer, Inc.60793-701-10GL295730-Apr-202630-Apr-2027Bicillin L-A (penicillin G benzathine injectable suspension), 1,200,000 units/2 mLPfizer, Inc.60793-701-10GL295630-Apr-202630-Apr-2027Bicillin L-A (penicillin G benzathine injectable suspension), 1,200,000 units/2 mLPfizer, Inc.60793-701-10GL296130-Jun-202630-Jun-2027Bicillin L-A (penicillin G benzathine injectable suspension), 1,200,000 units/2 mLPfizer, Inc.60793-701-10GL295830-Jun-202630-Jun-2027Bicillin L-A (penicillin G benzathine injectable suspension), 1,200,000 units/2 mLPfizer, Inc.60793-701-10GL295931-Aug-202631-Aug-2027Bicillin L-A (penicillin G benzathine injectable suspension), 1,200,000 units/2 mLPfizer, Inc.60793-701-10GL296031-Aug-202631-Aug-2027Bicillin L-A (penicillin G benzathine injectable suspension), 1,200,000 units/2 mLPfizer, Inc.60793-701-10GT260331-Oct-202631-Oct-2027Bicillin L-A (penicillin G benzathine injectable suspension), 1,200,000 units/2 mLPfizer, Inc.60793-701-10GT260031-Oct-202631-Oct-2027Bicillin L-A (penicillin G benzathine injectable suspension), 1,200,000 units/2 mLPfizer, Inc.60793-701-10GT260231-Oct-202631-Oct-2027Bicillin L-A (penicillin G benzathine injectable suspension), 2,400,000 units/4 mLPfizer, Inc.60793-702-10GT245031-May-202631-Dec-2026Bicillin L-A (penicillin G benzathine injectable suspension), 2,400,000 units/4 mLPfizer, Inc.60793-702-10GT258231-May-202631-Dec-2026Bicillin L-A (penicillin G benzathine injectable suspension), 2,400,000 units/4 mLPfizer, Inc.60793-702-10GT259830-Sep-202630-Apr-2027Bicillin L-A (penicillin G benzathine injectable suspension), 2,400,000 units/4 mLPfizer, Inc.60793-702-10GT259930-Sep-202630-Apr-2027Bicillin L-A (penicillin G benzathine injectable suspension), 2,400,000 units/4 mLPfizer, Inc.60793-702-10GT260430-Nov-202630-Jun-2027Bicillin L-A (penicillin G benzathine injectable suspension), 2,400,000 units/4 mLPfizer, Inc.60793-702-10GT260630-Nov-202630-Jun-2027Bicillin L-A (penicillin G benzathine injectable suspension), 2,400,000 units/4 mLPfizer, Inc.60793-702-10GT260831-Mar-202631-Oct-2026Bicillin L-A (penicillin G benzathine injectable suspension), 2,400,000 units/4 mLPfizer, Inc.60793-702-10HE399030-Nov-202630-Jun-2027Flumazenil Injection, 0.1 mg/mL, 10 mL vialBaxter36000-149-10A0H0421A31-Jul-202631-Jan-2027Flumazenil Injection, 0.1 mg/mL, 10 mL vialBaxter36000-149-10A0H0523A31-Jul-202631-Jan-2027

来源:FDA 官方药品与生物制品信息 · fda.gov